Pharmacological alternatives for the alleviation of back pain

Expert Opinion on Pharmacotherapy

Volumn 5, Issue 10, 2004, Pages 2091-2098

  Bogduk, Nikolai ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Analgesic; Antidepressants; Back pain; Drugs; Injection; Muscle relaxants; NSAIDs; Opioids; Prolotherapy; Treatment

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; BACLOFEN; CAFFEINE; CARISOPRODOL; CHLORMEZANONE; CODEINE; CORTICOSTEROID; CYCLOBENZAPRINE; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; DANTROLENE; DEXTROPROPOXYPHENE; DIAZEPAM; IBUPROFEN; METHOCARBAMOL; MORPHINE; MUSCLE RELAXANT AGENT; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; ORPHENADRINE; PARACETAMOL; PLACEBO; SALIX EXTRACT; SODIUM CHLORIDE; TETRAZEPAM; TIZANIDINE; TRAMADOL; UNINDEXED DRUG;

ANALGESIA; ANALGESIC ACTIVITY; BACKACHE; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC DISEASE; CLINICAL TRIAL; DISEASE EXACERBATION; DIZZINESS; DROWSINESS; DRUG COST; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; EVIDENCE BASED MEDICINE; HUMAN; LOW BACK PAIN; LUMBAR SPINE; MEDICAL DOCUMENTATION; OUTCOMES RESEARCH; REVIEW; RISK BENEFIT ANALYSIS; XEROSTOMIA;

ANALGESICS; ANTIDEPRESSIVE AGENTS; BACK PAIN; HUMANS; INJECTIONS; LOW BACK PAIN; MUSCLE RELAXANTS, CENTRAL;

EID: 6444232582     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.5.10.2091     Document Type: Review

References (63)

1. BOGDUK N, MCGUIRK B: Medical management of acute and chronic low back pain. An evidence-based approach. Elsevier, Amsterdam, The Netherlands (2002).
2. AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS AND NORTH AMERICAN SPINE SOCIETY: Draft Clinical Algorithm on Low back Pain. American Academy of Orthopaedic Surgeons and North American Spine Society (1996).
3. AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS: Evidence-based recommendations for patients with acute activity intolerance due to low back symptoms. Orthopaedic Update (1995) 5:625-632.
4. NATIONAL ADVISORY COMMITTEE ON CORE HEALTH AND DISABILITY SERVICES, ACCIDENT REHABILITATION AND COMPENSATION INSURANCE CORPORATION: Clinical Practice Guidelines. Acute Low Back Problems in Adults: Assessment and Treatment. Core Services Committee, Ministry of Health Wellington, New Zealand (1995).
5. AGENCY FOR HEALTH CARE POLICY AND RESEARCH: Acute Low Back Pain in Adults: Assessment and Treatment. US Department of Health and Human Services Rockville, USA (1994).
6. AUSTRALIAN ACUTE MUSCULOSKELETAL PAIN GUIDELINES GROUP: Evidence-Based Management of Acute Musculoskeletal Pain. Australian Academic Press, Brisbane, Australia (2003).
7. DE CRAEN AJM, DI GIULIO G, LAMPE-SCHOENMAECKERS AJEM, KESSELS AGH, KLEIJNEN J: Analgesic efficacy and safety of paracetamol-codeine combinations versus paracetamol alone: a systematic review. Br. Med. J. (1996) 313:321-325.
8. BROWN FL, BODISON S, DIXON J, DAVIS W, NOWOSLAWSKI J: Comparison of diflunisal and acetaminophen with codeine in the treatment of initial or recurrent acute low back pain. Clin. Ther. (1986) 9(Suppl. C):52-58.
9. INNES GD, CROSKERRY P, WORTHINGTON J, BEVERIDGE R, JONES D: Ketorolac versus acetaminophen-codeine in the emergency department treatment of acute low back pain. J. Emerg. Med. (1998) 16 549-556.
10. MUNCIE HL, KING DE, DEFORGE B: Treatment of mild to moderate pain of acute soft tissue injury: diflunisal versus acetaminophen with codeine. J. Fam. Pract. (1986) 23:125-127.
11. KUNTZ D, BROSSEL R: Action antalgique et tolerance clinique de l'association paracetamol 500 mg-caffeine 50 mg versus paracetamol 400 mg dextropropoxyphene 30 mg dans les rachialgies. Presse Med. (1996) 25:1171-1174.
12. EVANS DP, BURKE MS, NEWCOMBE RG: Medicines of choice in low back pain. Curr. Med. Res. Opin. (1980) 6:540-547.
13. VAN TULDER MW, KOES BW, BOUTER LM: Conservative treatment of acute and chronic nonspecific low back pain. A systematic review of randomised controlled trials of the most common interventions. Spine (1997) 22:2128-2156.
14. VAN TULDER MW, WADDELL G: Conservative treatment of acute and subacute low back pain. In: Neck and Back Pain: The Scientific Evidence of Causes, Diagnosis, and Treatment. Nachemson A, Jonsson E (Eds), Lippincott, Williams & Wilkins, Philadelphia, USA (2000 ):241-269.
15. VAN TULDER MW, SCHOLTEN RJPM, KOES BW, DEYO RA: Nonsteroidal anti-inflammatory drugs for low back pain. A systematic review within the framework of the Cochrane Collaboration Back Review Group. Spine (2000) 25:2501-2513.
16. POHJOLAINEN T, JEKUNEN A, AUTIO L, VUORELA H: Treatment of acute low back pain with COX-2-selective anti-inflammatory drug nimesulide. Results of a randomised, double-blind comparative trial versus ibuprofen. Spine (2000) 25:1579-1585.
17. NADLER SF, STEINER DJ, ERASALA GN et al.: Continuous low-level heat wrap therapy provides more efficacy than ibuprofen and acetaminophen for acute low back pain. Spine (2002) 27 1012-1017.
18. JOHNSON EW: Editorial: the myth of skeletal muscle spasm. Am. J. Phys. Med. (1989) 68:1.
19. ANDERSSON G, BOGDUK N, DELUCA C et al.: Muscle: Clinical Perspectives. In: New Perspectives on Low Back Pain. Frymoyer JW Gordon SL (Eds), American Academy of Orthopaedic Surgeons, Park Ridge, Illinois, USA (1989):293-334.
20. VAN TULDER MW, TOURAY T, FURLAN AD, SOLWAY S, BOUTER LM: Muscle relaxants for nonspecific low back pain: a systematic review within the framework of the Cochrane Collaboration. Spine (2003) 28:1978-1992.
21. GOLD RH: Orphenadrine citrate: sedative or muscle relaxant? Clin. Ther. (1978) 1:451-453.
22. TERVO T, PETAJA L, LEPISTO P: A controlled clinical trial of a muscle relaxant analgesic combination in the treatment of acute lumbago. Br. J. Clin. Pract. (1976) 30:62-64.
23. MOLL Z: Zur Therapie akuter lumbovertebraler Syndrome durch optimale medikamentöse Muskelrelaxation mittels Diazepam. Med. Welt. (1973) 24:1747-1751.
24. HINGORANI K: Diazepam in backache: a double-blind controlled trial. Ann. Phys. Med. (1966) 8:303-306.
25. CASALE R: Acute low back pain: symptomatic treatment with a muscle relaxant drug. Clin. J. Pain (1988) 4:81-88.
26. HINDLE TH: Comparison of carisoprodol, butabarbital, and placebo in treatment of the law back syndrome. Calif. Med. (1972) 117:7-11.
27. MIDDLETON RSW. A comparison of two analgesic muscle relaxant combinations in acute back pain. Br. J. Gen. Pract. (1984) 38 107-109.
28. SWEETMAN BJ, BAIG A, PARSONS DL: Mefenamic acid, chlormezanone-paracetamol, ethoheptazine-aspirin-meprobramate: a comparative study in acute low back pain. Br. J. Clin. Pract. (1987) 41:619-624.
29. BERRY H, HUTCHINSON DR: A multicentre placebo-controlled study in general practice to evaluate the efficacy and safety of tizanidine in acute low-back pain. J. Int. Med. Res. (1988) 16 75-82.
30. BERRY H, HUTCHINSON DR: Tizanidine and ibuprofen in acute low-back pain: results of a double-blind multicentre study in general practice. J. Int. Med. Res. (1988) 16:83-91.
31. BAPTISTA R, BRIZZI J, DUTTA F et al.: Terapeutica da lombalgia com a tizanidina (DS 103-282), un novo agente miospasmolitico. Estudo multicentrico, duplo-cego e compartivo. Folha Medica (1988) 96:119-123.
32. LEPISTO P: A comparative trial of DS 103-282 and placebo in the treatment of acute skeletal muscle spasms due to disorders of the back. Ther. Res. (1979) 26:454-459.
33. DAPAS F, HARTMAN SF, MARTINEZ L et al.: Baclofen for the treatment of acute low-back syndrome: a double-blind comparison with placebo. Spine (1985) 10:345-349.
34. BARRATTA RR: A double-blind study of cyclobenzaprine and placebo in the treatment of acute musculoskeletal conditions of the low back. Curr. Ther. Res. (1982) 32:646-652.
35. BORENSTEIN DG, LACKS S, WIESEL SW. Cyclobenzaprine and naproxen versus naproxen alone in the treatment of acute low back pain and muscle spasm. Clin. Ther. (1990) 12:125-131.
36. BIANCHI M: Evaluation of cyclobenzaprine for skeletal muscle spasm of local origin. Clinical evaluation of Flexeril (Cyclobenzaprine NCl/MSD). Minneapolis, MN. Postgrad. Med. Communications (1978):25-29.
37. BROWNING R, JACKSON JL, O'MALLEY PG: Cyclobenzaprine and back pain: a meta-analysis. Arch. Int. Med. (2001) 161:1613-1620.
38. CHRUBASIK S, EISENBERG E, BALAN, WEINBERGER T, LUZZATI R, CONRADT C: Treatment of low back pain exacerbations with willow bark extract: a randomised double-blind study. Am. J. Med. (2000) 109 9-14.
39. CHRUBASIK S, KUNZEL O, MODELA, CONRADT C, BLACK A: Treatment of low back pain with a herbal or synthetic anti-rheumatic: a randomised controlled study. Willow bark extract for low back pain. Rheumatology (2001) 40:1388-1393.
40. BIRBARA CA, PUOPOLO AD, SHELDON EA et al.: Treatment of chronic low back pain with etoricoxib, a new cyclo-axygenase-2 selective inhibitor: improvement in pain and disability - a randomised, placebo-controlled, 3-month trial. J. Pain (2003) 4:307-315.
41. MOULIN DE, IEZZI A, AMIREH R, SHARPE WKJ, BOYD D, MERSKEY H: Randomised trial of oral morphine for chronic non-cancer pain. Lancet (1996) 347:143-147.
42. JAMISON RN, RAYMOND SA, SLAWSBY EA, NEDELJKOVIC SS, KATZ NP: Opioid therapy for chronic noncancer back pain. A randomised prospective study. Spine (1998) 23:2591-2600.
43. SCHNITZER TJ, GRAY WL, PASTER Z, KAMIN M: Efficacy of tramadol in treatment of chronic low back pain. J. Rheumatol. (2000) 27:772-778.
44. TURNER JA, DENNY MC: Do antidepressant medications relieve chronic low back pain? J. Fam. Pract. (1993) 37:545-553.
45. SALERNO S, BROWNING R, JACKSON SL: The effect of antidepressant treatment of chronic back pain. A meta-analysis. Arch. Int. Med. (2002) 162:19-24.
46. ARBUS L, FAJADET B, AUBERT D, MORRE M, GOLDBERGER E: Activity of tetrazepam (myolastan) in low back pain: a double-blind trial versus placebo. Clin. Trials J. (1990) 27:258-267.
47. SLAZMANN E, PFROINGER W, PAAL G et al.: Treatment of chronic lowback syndrome with tetrazepam in a placebo controlled double-blind trial. J. Drug Dev. (1992) 4:219-228.
48. WÖRZ R, BOLTEN W, HELLER B et al.: Flupirtin im Vergleich zu Chlormezanon und Placebo bei chronischen muskuloskeletallen Rückensmerzen. Fortschr. Ther. (1996) 114:35-36.
49. PRATZEL HG, ALKEN RG, RAMM S: Efficacy and tolerance of repeated oral doses of tolperisone hydrochloride in the treatment of painfull reflex muscle spasm: results of a prospective placebo-controlled double-blind trial. Pain (1996) 67:417-425.
50. NELEMANS PJ, DE BIE RA, DEVET HCW. STURMANS F: Injection therapy for subacute and chronic benign low back pain. Spine (2001) 26:501-515.
51. BOGDUK N: Spine update: epidural steroids. Spine (1995) 20:845-848.
52. COLLEE G, DIJKMANS BAC, VANDERBROUCKE JP, CATS A: Iliac crest pain syndrome in low back pain: a double-blind, randomised study of local injection therapy. J. Rheumatol. (1991) 18:1060-1063.
53. HAMEROFF SR, CRAGO BR, BLITT CD, WOMBLE J, KANEL J: Comparison of bupivacaine, etidocaine, and saline for trigger-point therapy. Anaesth. Analg. (1981) 60:752-755.
54. SONNE M, CHRISTENSEN K, HANSEN SE, JENSEN EN: Injection of steroids and local anaesthetics as therapy for low back pain. Scand. J. Rheum. (1985) 14:343-345.
55. ONGLEY MJ, KLEIN RG, DORMAN TA, EEK BC, HUBERT LJ: A new approach to the treatment of chronic low back pain. Lancet (1987) 2:143-146.
56. KLEIN RG, EEK BC, DELONG WB, MOONEY V: A randomised double-blind trial of dextrose-glycerine-phenol injections for chronic, low back pain. J. Spinal. Dis. (1993) 6:23-33.
57. YELLAND MJ, GLASZIOU PP, BOGDUK N, SCHLUTER PJ, MCKERNON M: Prolotherapy injections, saline injections, and exercises for chronic low-back pain: a randomised trial. Spine (2004) 29:9-16.
58. BOGDUK N: Management of chronic low back pain. Med. J. Aust. (2004) 180:79-83.
59. FOSTER L, CLAPP L, ERICKSON M, JABBARI B: Botulinum. toxin A and chronic low back pain. A randomised, double-blind study. Neurology (2001) 56:1290-1293.
60. BENNETT G, SERAFINI M, BURCHIEL K et al.: Evidence-based review of the literature on intrathecal delivery of pain medication. J. Pain Symptom Manage. (2000) 20:S12-S36.
61. MCGUIRK B, KING W, GOVIND J, LOWRY J, BOGDUK N: The safety, efficacy, and cost-effectiveness of evidence-based guidelines for the management of acute low back pain in primary care. Spine (2001) 26:2615-2622.
62. GRAZIOTTI PJ, GOUCKE CR: The use of oral opioids in patients with chronic noncancer pain. Management strategies. Med. J. Aust. (1997) 167:30-31.
63. CANADIAN PAIN SOCIETY. Use of opioid analgesia for the treatment of chronic non-cancer pain - a consensus statement and guidelines from the Canadian Pain Society. Pain Res. Manage. (1998) 3:197-208.